Table 3 Number of patients exceeding the 95th or 5th percentile of IFN- γ dependent laboratory values during acute COVID-19 infection and at the two follow-ups (FU1, FU2).
Acute (n = 33) | FU1 (n = 34) | FU2 (n = 23) | 95th/5th percentile* | |
|---|---|---|---|---|
n (valid %) | n (valid %) | n (valid %) | ||
Neopterin [nmol/L] | 32 (97) | 18 (53) | 6 (26.1) | 9.10a |
Kyn [µmol/L] | 10 (30.3) | 11 (32.4) | 11 (47.8) | 2.48a |
Trp [µmol/L] | 26 (78.8) | 17 (50) | 0 (0) | 53.1b |
Phe [µmol/L] | 31 (93.9) | 8 (23.5) | 11 (47.8) | 83.4a |
Tyr [µmol/L] | 10 (30.3) | 16 (47.1) | 1 (4.4) | 59.5b |
Kyn/Trp [µmol/mmol] | 29 (87.9) | 25 (73.5) | 16 (69.6) | 35.1a |
Phe/Tyr [µmol/µmol] | 33 (100) | 28 (82.3) | 15 (65.2) | 0.95a |